Navigation Links
Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
Date:11/14/2007

NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- Xenomics, Inc. (the "Company") (OTC Pink Sheets: XNOM; FWB: XE7) a developer of next-generation medical DNA diagnostic technologies, announced today issuance of its US patent "Methods for detection of nucleic acid sequences in urine," RE39,920 that covers use of its proprietary transrenal nucleic acid technology in the area of infectious disease diagnostics and monitoring.

Transrenal nucleic acids (Tr-DNA and Tr-RNA) are fragments of DNA and RNA from cells dying throughout the body that cross the kidney barrier from blood to urine and can be used for genetic analysis. Xenomics' previous patents covered applications of the Tr-NA technology for prenatal genetic testing, tumor diagnostics and monitoring, and detection of rejection episodes after organ transplantation. The new patent covers diagnosis and monitoring of infectious diseases, the most rapidly growing area of molecular diagnostics.

The molecular diagnostic segments in general are projected to outperform the overall diagnostics market, growing from $13.8 billion in 2005 to $22.7 billion in 2010. Currently, the largest market application segment for molecular diagnostics is infectious disease testing.

Xenomics' scientists have detected in urine DNA and RNA fragments of different pathogens, including viruses, bacteria and parasites, that infected organs and tissues located outside of urinary system. Pulmonary tuberculosis, malaria, leishmania, HIV, H. pylori-induced ulcers of stomach and duodenum, cervical cancer caused by HPV (Human Papilloma Virus) are only some examples of diseases where the Tr-NA technology can be applied.

"The issuance of this patent significantly enhances our patent portfolio," commented Gianluigi Longinotti-Buitoni, Executive Chairman of Xenomics. "It is especially important for us now when several clinical tests for diagnosis of infectious diseases as well as for detecting tumors caused by viral infections are un
'/>"/>

SOURCE Xenomics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Calif. , May 6, 2015 ... biotechnology company in the emerging field of regenerative ... a meeting with the investment community to review ... cells) in spinal cord injury on Friday, May ... 1/2a clinical trial and future planned clinical activities ...
(Date:5/6/2015)... BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today reported ... Total revenues for the first quarter ... $136.8 million in the first quarter of 2014. Revenues ... million in royalty and license payments from PDL,s licensees ... net royalty payments from acquired royalty rights and a ...
(Date:5/6/2015)... PHILADELPHIA, May 6, 2015 Lannett Company, Inc. ... its fiscal 2015 third quarter ended March 31, 2015.  ... net sales rose 24% to $99.4 million from $80.0 ... 35% to $75.6 million, or 76% of net sales, ... and development (R&D) expenses decreased to $9.2 million from ...
Breaking Medicine Technology:Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8
... Marken, a leading logistics specialist supporting the life science industry, today announced ... office will handle the growing demand for management and support of Marken,s Japanese ... "Opening our ... science companies in Japan and across the Asia Pacific ...
... NEWTON, Mass. , Aug. 5 Microfluidics International Corporation (OTC Bulletin Board: ... Tuesday, August 10, 2010 , at 8:30am ET . , ... (Logo: http://photos.prnewswire.com/prnh/20090811/NE59652LOGO ) , , , ... ) , , , ...
Cached Medicine Technology:Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 2Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 3Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 4
(Date:5/6/2015)... Edvance360 LMS-SN , a leader in ... Software & Information Industry Association's (SIIA) 30th annual ... Learning Management Solution" category. Edvance360 LMS-SN won the ... this award seven years running, continued proof that Edvance360 ... industry. , "The honor of being a CODiE ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child ... center in Florida while under the influence of Flakka, according ... tapes released by CBS4’s Peter D’Oench records Doby distraught in ... is around one year old. The drug treatment center in ... not named. The residents polled by CBS Miami express concern ...
(Date:5/6/2015)... BC (PRWEB) May 06, 2015 ... hydrotherapy supplier, is excited to announce a new ... help reduce the industry’s carbon footprint while improving ... kits feature Eco-Flex™, the world’s first ... is a game-changer for hydrotherapists,” claims the company’s ...
(Date:5/6/2015)... 06, 2015 “ SideChef ” was featured on ... at the latest and coolest applications on the market for iOS, ... expert, conducted the app review and shared with viewers how this ... day when to be a good navigator people had to know ... now everyone is a master navigator. Well what if people could ...
(Date:5/6/2015)... 06, 2015 vcfo, a specialized consulting ... and operational support to optimize business performance and productivity, ... Lynch and Michael Scheaffer. Both Lynch and Scheaffer have ... experience. , “We are delighted to add Jack ... CEO. “Leveraging their background in financial management and leadership, ...
Breaking Medicine News(10 mins):Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2
... - BELLUS Health Inc. (TSX: BLU) reported today its ... and commented on the status of its efforts to ... reports a net loss of $11,520,000 ($0.23 per share), ... period in the previous year. For the year ended ...
... Toys That Speak To Autism" and Provides Important ... This weekend, Toys"R"Us and Babies"R"Us stores nationwide ... to benefit Autism Speaks, the nation,s leading organization ... funding research into the causes, prevention and treatments ...
... SANTA ANA, Calif., Feb. 26 MIND Research Institute ... of Advanced,Medical Optics (AMO), was recently elected to MIND,s ... education. He serves on numerous boards and,committees at the ... chairs the UCI,Foundation,s Board of Trustees, the Engineering Advisory ...
... Inn & Spa,s Artist,s Cottage is the next generation ... http://www.newscom.com/cgi-bin/prnh/20090226/NYFNSH01 )"Traditional spas just focus on the wellness ... Valley Inn & Spa. "At Ojai Valley Inn & ... our guests the opportunity to treat not just their ...
... and Make Patient Safety a PriorityPORTLAND, Ore., Feb. ... healthcare payers caught between member demands for better ... they also wrestle with business restructuring, declining budgets ... complexity of new technologies, treatments and drugs continues ...
... and News/Talk 750 WSB are teaming up to extend the Prostate Proactivity ... Saturday, February 28, from 9 a.m. to 5 p.m. at Kroger located ... ... February 26, 2009 -- Metro Atlanta men will have an additional opportunity ...
Cached Medicine News:Health News:BELLUS Health reports results for the fourth quarter of 2008 2Health News:BELLUS Health reports results for the fourth quarter of 2008 3Health News:BELLUS Health reports results for the fourth quarter of 2008 4Health News:BELLUS Health reports results for the fourth quarter of 2008 5Health News:BELLUS Health reports results for the fourth quarter of 2008 6Health News:BELLUS Health reports results for the fourth quarter of 2008 7Health News:BELLUS Health reports results for the fourth quarter of 2008 8Health News:BELLUS Health reports results for the fourth quarter of 2008 9Health News:BELLUS Health reports results for the fourth quarter of 2008 10Health News:BELLUS Health reports results for the fourth quarter of 2008 11Health News:BELLUS Health reports results for the fourth quarter of 2008 12Health News:BELLUS Health reports results for the fourth quarter of 2008 13Health News:BELLUS Health reports results for the fourth quarter of 2008 14Health News:BELLUS Health reports results for the fourth quarter of 2008 15Health News:BELLUS Health reports results for the fourth quarter of 2008 16Health News:BELLUS Health reports results for the fourth quarter of 2008 17Health News:BELLUS Health reports results for the fourth quarter of 2008 18Health News:BELLUS Health reports results for the fourth quarter of 2008 19Health News:BELLUS Health reports results for the fourth quarter of 2008 20Health News:BELLUS Health reports results for the fourth quarter of 2008 21Health News:BELLUS Health reports results for the fourth quarter of 2008 22Health News:BELLUS Health reports results for the fourth quarter of 2008 23Health News:BELLUS Health reports results for the fourth quarter of 2008 24Health News:BELLUS Health reports results for the fourth quarter of 2008 25Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 2Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 3Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Introducing a Kitchen for Your Mind: The Ojai Valley Inn & Spa Artist's Cottage 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 3Health News:Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign 2Health News:Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign 3
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: